— Know what they know.
Not Investment Advice

ANNX NASDAQ

Annexon, Inc.
1W: -7.7% 1M: +1.6% 3M: -25.6% YTD: -21.1% 1Y: +21.3% 3Y: +112.6% 5Y: -82.2%
$3.76
+0.06 (+1.62%)
After Hours: $3.73 (-0.03, -0.93%)
Weekly Expected Move ±11.9%
$3 $3 $4 $4 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 37 · $606.2M mcap · 176M float · 2.06% daily turnover · Short 50% of daily vol
Credit Risk of going bust: higher than 50% of companies Debt: 3.9% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 99.4%), Annexon, Inc. would be worth roughly what it owes.
Total debt $24.7M against a stock market value of $606.2M.
Distance to default 5.08 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $12.3M (short-term plus half of long-term), stock volatility 74.1%; Altman Z'' -11.11. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Supply Chain Overview

1 relationships
0
As Filer
counterparties named
1
As Counterparty
mentioned by others
2021-11-16
Earliest Filing
2021-11-16
Latest Filing

Mentioned As Counterparty

1 mentions

Other companies that named ANNX in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
LENZ Graphite Bio, Inc. customer Sublandlord entering into a sublease agreement with Graphite Bio, Inc. 2021-11-16 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-12 Earnings Release; Other Events; Exhibits View
2026-08-10 Officer/Director Change; Regulation FD; Exhibits View
2026-08-06 Other Events; Exhibits View
2026-07-30 Material Agreement; Financial Obligation; Other Events; Exhibits Agreement View
2026-06-12 Shareholder Vote View
2026-05-07 Earnings Release; Exhibits View
2026-03-30 Earnings Release; Exhibits View
2026-02-17 Departure/Election of Directors; Appointment of Officers View
2026-01-14 Regulation FD Disclosure; Financial Statements and Exhibits View
2026-01-12 Other Events; Financial Statements and Exhibits View
2025-11-14 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
2025-11-10 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-08-14 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-06-25 Material Modification to Rights of Security Holders; Financial Statements and Exhibits View
2025-06-09 Submission of Matters to a Vote of Security Holders View
2025-05-12 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-03-03 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-01-13 Other Events; Financial Statements and Exhibits View
2025-01-10 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
2024-12-16 Other Events; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms